Bradbury, A.; O’Donnell, R.; Drew, Y.; Curtin, N.J.; Sharma Saha, S.
Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting. Cancers 2020, 12, 1939.
https://doi.org/10.3390/cancers12071939
AMA Style
Bradbury A, O’Donnell R, Drew Y, Curtin NJ, Sharma Saha S.
Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting. Cancers. 2020; 12(7):1939.
https://doi.org/10.3390/cancers12071939
Chicago/Turabian Style
Bradbury, Alice, Rachel O’Donnell, Yvette Drew, Nicola J. Curtin, and Sweta Sharma Saha.
2020. "Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting" Cancers 12, no. 7: 1939.
https://doi.org/10.3390/cancers12071939
APA Style
Bradbury, A., O’Donnell, R., Drew, Y., Curtin, N. J., & Sharma Saha, S.
(2020). Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic Targeting. Cancers, 12(7), 1939.
https://doi.org/10.3390/cancers12071939